RED CELL THERAPEUTICS Trademark

Trademark Overview

On Tuesday, January 3, 2017, a trademark application was filed for RED CELL THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the RED CELL THERAPEUTICS trademark a serial number of 87287791. The federal status of this trademark filing is REGISTERED as of Tuesday, April 14, 2020. This trademark is owned by Rubius Therapeutics, Inc.. The RED CELL THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals
red cell therapeutics

General Information

Serial Number87287791
Word MarkRED CELL THERAPEUTICS
Filing DateTuesday, January 3, 2017
Status700 - REGISTERED
Status DateTuesday, April 14, 2020
Registration Number6035628
Registration DateTuesday, April 14, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Disclaimer with Predetermined Text"CELL"
Goods and ServicesScientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 12, 2017
Primary Code042
First Use Anywhere DateWednesday, December 9, 2015
First Use In Commerce DateWednesday, December 9, 2015

Trademark Owner History

Party NameRubius Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameRubius Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Tuesday, April 14, 2020REGISTERED-SUPPLEMENTAL REGISTER
Tuesday, March 10, 2020LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, March 5, 2020APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Thursday, March 5, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, March 5, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 5, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, March 5, 2020EXAMINERS AMENDMENT -WRITTEN
Friday, August 23, 2019NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Friday, August 23, 2019SUBSEQUENT FINAL EMAILED
Friday, August 23, 2019SUBSEQUENT FINAL REFUSAL WRITTEN
Saturday, August 3, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 2, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 2, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 12, 2019NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Monday, February 11, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 11, 2019NON-FINAL ACTION E-MAILED
Monday, February 11, 2019NON-FINAL ACTION WRITTEN
Monday, February 11, 2019USE AMENDMENT ACCEPTED
Wednesday, February 6, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 6, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 8, 2019AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, January 8, 2019USE AMENDMENT FILED
Wednesday, January 2, 2019TEAS AMENDMENT OF USE RECEIVED
Friday, January 4, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 4, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 2, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 2, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 2, 2018NON-FINAL ACTION E-MAILED
Monday, July 2, 2018NON-FINAL ACTION WRITTEN
Wednesday, May 2, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 2, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, January 13, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, January 13, 2018FINAL REFUSAL E-MAILED
Saturday, January 13, 2018FINAL REFUSAL WRITTEN
Wednesday, October 25, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 25, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 18, 2017ASSIGNED TO LIE
Wednesday, October 4, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 4, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 4, 2017NON-FINAL ACTION E-MAILED
Tuesday, April 4, 2017NON-FINAL ACTION WRITTEN
Tuesday, March 28, 2017ASSIGNED TO EXAMINER
Thursday, January 12, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

therapeutics cell research scientific development others biotechnology pharmaceuticals field consultation pharmaceutical medical